Blindness risk double in men

Article

Despite the higher rate of prevalence in women, it is men who are more likely to suffer severe vision loss as a result of idiopathic intracranial hypertension (IIH), according to study results published online ahead of print by Neurology.

Despite the higher rate of prevalence in women, it is men who are more likely to suffer severe vision loss as a result of idiopathic intracranial hypertension (IIH), according to study results published online ahead of print by Neurology.

Beau B. Bruce, MD of Emory University, Atlanta, US and colleagues conducted a medical record review of IIH patients (n=721) in three hospitals. Subjects, who underwent neuro-ophthalmologic testing, were segregated for gender (male, n=66; female, n=655) and a statistical comparison was undertaken.

The men included in the study were older and more likely to suffer from sleep apnoea than the women: 37 vs 28 years and 24% vs 4%, respectively. As a first symptom of IIH, men tended to report visual disturbance and women, headaches. At the final follow-up point, mean visual acuity was worse for men than for women. After logistical regression analysis, the researchers determined that the 2.1 times increased chance of men developing severe visual loss when compared with women was correlated to sex.

The team therefore concluded that men are more than twice as likely to sustain severe vision loss, to the extent of being declared legally blind, than women, which may be related to the differences in the symptom profile presented by the different genders.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
3 experts are featured in this series.
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Sunita Radhakrishnan, MD, an associate at the Glaucoma Center of San Francisco, speaks at the annual Glaucoma 360 meeting about electrical neurostimulation.
3 experts are featured in this series.
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.